InFlectis BioScience
2013
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Series A
LATEST DEAL TYPE
$6.76M
LATEST DEAL AMOUNT
5
INVESTORS
Description
Developer of small molecule drugs intended to maximize the commercial value of each of its products, improve patient care and generate significant financial returns to its shareholders. The company's small molecule drugs identify preclinical-stage development products that modulate key proteins involved in misfolded protein disorders areas through early proof-of-concept, enabling patients to develop a stronger cellular defense system.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 21 rue La Noue Bras de Fer
- 44200 Nantes
- France
+33 02 00 00 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore InFlectis BioScience’s full profile, request a free trial.
InFlectis BioScience Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 01-Jun-2016 | $6.76M | 00.000 | Completed | Generating Revenue | |
| 2. Seed Round | 13-Jan-2015 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 1. Grant | 01-Jan-2014 | $411K | Completed | Generating Revenue |
InFlectis BioScience Competitors (16)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CellBiosciences | Formerly VC-backed | San Jose, CA | 000.00 | 000000&0 | 000.00 | |
| 0000000000 | Formerly PE-Backed | Germantown, MD | 0 | 000.00 | 00000000 | 000.00 |
| 000000 00000000000 | Failed Transaction (M&A) | Cambridge, MA | 000 | 00000 | 000000&0 | |
| 00000 00000000 | Venture Capital-Backed | San Francisco, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 000000000 00000000 | Venture Capital-Backed | Cambridge, MA | 00 | 000.00 | 0&0 |
InFlectis BioScience Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| CM-CIC Investissement | Growth/Expansion | 000 0000 | 000000 0 | |||
| Remiges Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| GO Capital (France) | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Participations Besançon | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| French Research Ministry | Government | 000 0000 | 000000 0 |
InFlectis BioScience Executive Team (3)
InFlectis BioScience Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Jérôme Guéret | GO Capital (France) | Board Member | 000 0000 |